Navigation Links
Genzyme Reports Strong Second-Quarter Growth
Date:7/23/2008

/p>

services sold $(6,311) $(300,330)

Selling, general and

administrative $(31,904) $(347,305)

Research and development $(175,000) $(16,092) $(381,861)

Amortization of intangibles $(55,605) $(55,605)

Purchase of in-process

research and development $-

Equity in income (loss) of

equity method investments $-

Minority interest $563

Gains (losses) on

investments in equity

securities $9,153

Other $19

Investment income $13,352

Interest expense $(1,149)

Summary:

Income (loss) before income

taxes $(175,000) $(55,605) $(54,307) $107,971

(Provision for) benefit

from income taxes $33,749 $29,615 $16,834 $(38,407)

Net income (loss) $(141,251) $(25,990) $(37,473) $69,564

Net income (loss) per share:

Basic $(0.53) $(0.10) $(0.14) $0.26

Diluted (1) $(0.50) $(0.09) $(0.13) $0.25

Weighted average shares

outstanding:

Basic 266,904

Diluted (1) 284,262

(1) GAAP As-Reported diluted earnings per share and diluted weighted

average shares outstanding reflect the adoption of EITF 04-8. In

accordance with the provisions of EITF 04-8, interest and debt fee
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Genzyme Receives Approval to Market Elaprase(R) in Japan
5. Genzyme Recognized by Scientists as a Top Employer
6. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
7. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
8. Genzyme Launches Cholestagel(R) in Europe
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... collagenase-based products marketed as XIAFLEX ® (collagenase ... XIAPEX ® in the EU, today announced ... Phase 2a study of CCH for the potential ... results showed that all three doses of CCH ...
(Date:8/21/2014)... DUBLIN, Ireland , August 21, 2014 ... and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the ... Market 2014-2018"  report to their offering.  ... also known as hormone therapy, is a ... longer being produced by the body. This ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 Mathematic ... at Harvard University , and funded by the ... aggressive cells within tumors can be visually identified for elimination. ... tumor,s growth. The study, which shows a topological map of ... needed time in cancer research, for while tumor cells can ...
(Date:8/21/2014)... Ontotext S4 , The Self ... . Now the same enterprise hardened text mining, ... unstructured data is available to start-ups and mid-size businesses ... Organizations that do not have resources to evaluate and ... S4 since there is no need for on premise ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
... , , , , , Other important parameters for optimizing electroporation., , , ... Field strength , , Pulse length ... field pulses , Adjustment , ... of DNA/RNA , Influence , of ...
... , , , , , , , Table A , , ... , , <TD , ... <TD align=middle , ... colSpan=2> Heat of Vaporization , <TD align=middle ...
... , , , , , Contents , , , ... 1 , Measuring station and accessories ... 2 , Testing conditions and pipetting conditions , ... Calibrating pipettes and bottletop dispensers , / mode of ...
Cached Biology Technology:Optimizing electroporation parameters 2Optimizing Bchi Rotary Evaporator Applications 2Optimizing Bchi Rotary Evaporator Applications 3Optimizing Bchi Rotary Evaporator Applications 4Optimizing Bchi Rotary Evaporator Applications 5Optimizing Bchi Rotary Evaporator Applications 6Optimizing Bchi Rotary Evaporator Applications 7Optimizing Bchi Rotary Evaporator Applications 8Optimizing Bchi Rotary Evaporator Applications 9Optimizing Bchi Rotary Evaporator Applications 10Optimizing Bchi Rotary Evaporator Applications 11Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 2Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 3Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 4Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 5Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 6Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 7Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 8Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 9Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 10Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 11Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 12Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 13Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 14Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 15Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 16Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 17Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 18Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 19Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 20Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 21Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 22Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 23Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 24Brinkmann/Eppendorf SOP, Standard Operating Procedure for Pipettes 25
(Date:8/22/2014)... the birds and the bees. But that old ... fertilized. The fertilization process for flowering plants is ... male and female reproductive cells. New research from ... Munich, and including Carnegie,s Wolf Frommer, David Ehrhardt, ... signaling process that guides flowering plant fertilization. It ...
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan Service ... agreed to a partnership with Gabriel Health Institute, ... fastest growing Certified Nursing Assistant preparatory schools. ...  an exclusive member of Binary,s LiveScan service provider,s ... will improve its service capabilities by widening ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3
... Reducing Emissions from Deforestation and Forest Degradation ... that aims to financially compensate landowners and stewards ... as promoting forest conservation, sustainable forest management and ... and implemented correctly, REDD+ has the potential to ...
... new signaling pathway, which is important for the regulation ... an international team of scientists led by prof Ivan ... studied the involvement of ubiquitin, a universally present signaling ... scientific journal " Nature " the scientists report a ...
... the first ever European-wide retrospective analysis presented today at ... trientine continue to be effective treatments, providing positive survival ... liver transplant. , Wilson disease is a rare genetic ... the body effectively, leading to excess copper build up, ...
Cached Biology News:REDD+, Technical, Socioeconomic and Political Dimensions 2REDD+, Technical, Socioeconomic and Political Dimensions 3A new signaling pathway of the immune system is elucidated 2European-wide study confirms benefits of D-penicillamine and trientine for Wilson disease 2
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
NATIVE RAT OSTEOCALCIN...
... Specifications(L x W x H): 17 ... 5/16"18.7 lbsCapacity: 12 slidesTime: Programmable 0 - ... denaturation and hybridization steps 40 user programmable ... and Fixed temperature) Rapid temperature ramp-up from ...
Defender against cell death 1...
Biology Products: